Name | Research |
Anthony Carruthers, PhD* Biochem & Mol Biology | Sugar transport |
Marcus Cooper, MD Cardiology | Role of LRP130, and its effect on mitochondrial biology, in non-alcoholic fatty liver disease. |
Silvia Corvera, MD* Molecular Medicine | Insulin action, membrane trafficking glucose transporters, exocytosis |
Michael Czech, PhD* Molecular Medicine | Insulin action, glucose transport |
Roger Davis, PhD* Molecular Medicine | Study of the role of MAP kinases in insulin action and insulin secretion |
Paul Dobner, PhD* Mol. Genetics & Microbiology | Neurotensin, fat, metabolism, hormones |
Kevin Fogarty, MS* Physiology | Biomedical Cell Imaging |
Guangping Gao, PhD* Gene Therapy | Molecular pathogenesis and gene therapy of type II diabetes. This will be accomplished by combining unique tissue tropism of AAV serotype vectors with tissue specific, pharmacologically and micro RNA regulated gene expression cassettes for either beta-cell ablation and/or gene transfer |
Olga Hardy, MD* Pediatrics | The role of adipose inflammation in the pathogenesis of obesity-related comorbidities in adolescents |
Stephen Jones, PhD Cell Biology | Transgenic mice, knockout mice, mouse models, cancer |
Norman Kennedy, PhD* Molecular Medicine | Mechanisms of Insulin Resistance |
Catarina Kiefe, MD, PhD* Quantitative Health Sciences | |
Jason Kim, PhD* Molecular Medicine | Obesity, insulin resistance and type 2 diabetes. Role of inflammation in diabetes and cardiovascular complications. Metabolic phenotying of transgenic mouse models of obesity, diabetes and its complications |
David Lambright, PhD* Molecular Medicine | Membrane trafficking, G proteins, phosphoinositide signaling |
Nathan Lawson, PhD* Gene Func. & Exp. | Work to dissect the signals that are required for proper pancreas development and function |
John Leszyk, PhD* Biochem. & Mol. Pharm. | Protein microanalysis |
Sherry Pagoto, PhD* Prev. & Behav. Medicine | Psychiatric co-morbidities of obesity and type 2 diabetes; role of stress in development of insulin resistance |
Joel Richter, PhD* Molecular Medicine | The role of CPEB-mediated translational control in insulin-signaling and diabetes. |
Hayla Sluss, PhD Medicine/Endocrinology | p53 connection to obesity in fat physiology, pathology and role in diabetes |
Juerg Straubhaar, PhD* Molecular Medicine | Bioinformatics Core Director |
Heidi Tissenbaum, PhD* Molecular Medicine | Genetic and molecular analysis of new genes in the insulin-like signaling pathway in C. elegans. |
Fumihiko Urano, MD, PhD* Gene Func. & Exp. | PI 3-kinase and its targets in insulin-responsive cells |
Marion Walhout, PhD* Neurobiology | Fat storage problems in obesity and lipodystrophy in the development of type 2 diabetes |
Yong-Xu Wang, PhD* Gene Func. & Exp. | Transcriptional control of fatty acid and glucose metabolism and its implications in obesity and diabetes |
| * = Primary Members | |